Medicure (FRA:NGQ1) Accounts Payable & Accrued Expense : €5.67 Mil (As of Mar. 2025)

View and export this data going back to . Start your Free Trial

What is Medicure Accounts Payable & Accrued Expense?

Medicure's quarterly accounts payable & accrued expense increased from Sep. 2024 (€5.04 Mil) to Dec. 2024 (€5.38 Mil) and increased from Dec. 2024 (€5.38 Mil) to Mar. 2025 (€5.67 Mil).

Medicure's annual accounts payable & accrued expense declined from Dec. 2022 (€5.47 Mil) to Dec. 2023 (€5.21 Mil) but then increased from Dec. 2023 (€5.21 Mil) to Dec. 2024 (€5.38 Mil).

Medicure Accounts Payable & Accrued Expense Historical Data

The historical data trend for Medicure's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure Accounts Payable & Accrued Expense Chart

Medicure Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

6.20

5.13

5.47

5.21

5.38

Medicure Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															5.23	5.62	5.04	5.38	5.67

Medicure Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Medicure Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (FRA:NGQ1) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

MCUJF:USA MPH:Canada

Address

2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.medicure.com

Medicure Inc is a biopharmaceutical company engaged in the research, development and commercialization of human therapeutics. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure Headlines

No Headlines